EUR 15.55
(-4.01%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 69.72 Million EUR | 29.19% |
2022 | 53.97 Million EUR | -7.27% |
2021 | 58.2 Million EUR | -20.72% |
2020 | 73.42 Million EUR | 198.56% |
2019 | 24.59 Million EUR | 323.19% |
2018 | 5.81 Million EUR | 76.72% |
2017 | 3.28 Million EUR | 70.47% |
2016 | 1.92 Million EUR | -43.88% |
2015 | 3.43 Million EUR | -74.17% |
2014 | 13.31 Million EUR | 83.41% |
2013 | 7.25 Million EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 66.37 Million EUR | 0.0% |
2023 FY | 69.72 Million EUR | 29.19% |
2023 Q4 | 69.72 Million EUR | 0.0% |
2023 Q2 | 56.88 Million EUR | 0.0% |
2022 Q4 | 53.97 Million EUR | 0.0% |
2022 Q2 | 47.3 Million EUR | 0.0% |
2022 FY | 53.97 Million EUR | -7.27% |
2021 Q4 | 58.2 Million EUR | 0.0% |
2021 FY | 58.2 Million EUR | -20.72% |
2021 Q2 | 59.59 Million EUR | 0.0% |
2020 FY | 73.42 Million EUR | 198.56% |
2020 Q2 | 19.69 Million EUR | 0.0% |
2020 Q4 | 73.42 Million EUR | 0.0% |
2019 FY | 24.59 Million EUR | 323.19% |
2019 Q2 | 16.96 Million EUR | 0.0% |
2019 Q4 | 24.59 Million EUR | 0.0% |
2018 Q2 | 6.79 Million EUR | 0.0% |
2018 Q4 | 5.81 Million EUR | 0.0% |
2018 FY | 5.81 Million EUR | 76.72% |
2017 Q2 | 2.68 Million EUR | 0.0% |
2017 Q4 | 3.28 Million EUR | 0.0% |
2017 FY | 3.28 Million EUR | 70.47% |
2016 Q4 | 1.92 Million EUR | 0.0% |
2016 FY | 1.92 Million EUR | -43.88% |
2016 Q2 | 2.72 Million EUR | 0.0% |
2015 Q4 | 3.42 Million EUR | 0.0% |
2015 FY | 3.43 Million EUR | -74.17% |
2015 Q2 | 10.69 Million EUR | 0.0% |
2014 FY | 13.31 Million EUR | 83.41% |
2013 FY | 7.25 Million EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Fresenius Medical Care AG & Co. KGaA | 19.1 Billion EUR | 99.635% |
Fresenius SE & Co. KGaA | 25.63 Billion EUR | 99.728% |
LIMES Schlosskliniken AG | 16.6 Million EUR | -319.916% |
Maternus-Kliniken Aktiengesellschaft | 206.49 Million EUR | 66.232% |
MEDICLIN Aktiengesellschaft | 742.57 Million EUR | 90.61% |
RHÖN-KLINIKUM Aktiengesellschaft | 499.09 Million EUR | 86.029% |
VITA 34 AG | 135.58 Million EUR | 48.57% |